oldid22156

Lek grows 21%

Slovenian drugmaker Lek, which owns PharmaTech TA„srgu-Mures, last year recorded sales worth 24m euros on the Romanian market, up 21% since 2001. Consequently, the company's market share increased from 3.5% to 3.9%. However, Lek also found it difficult to ge...